CEO and Chairman of Adaptive Biotechnologies Corp (NASDAQ:ADPT), Robins Chad M, sells 16,790 shares worth $995,348
According to Adaptive Biotechnologies Corp's most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Dec 30 09:00 PM, company CEO and Chairman, Robins Chad M disclosed selling 16,790 shares at a cost of $59.28. At the time of this transaction (Dec 29), this trade was worth $995,348 in total. As of Dec 29, Robins Chad M now owns 1,778,180 shares in total worth about $105,623,892.0.
For the last few recent trades made by Adaptive Biotechnologies Corp (NASDAQ:ADPT) CEO and Chairman, Robins Chad M, we have the following information:
- SEC Form 4 filing: Dec 28: Sold 16,250 shares at the rate of $60.95 per share. Total worth of this trade was $990,496. Total number of shares owned as of Dec 28 were 1,778,180
- SEC Form 4 filing: Dec 30: Sold 16,520 shares at the rate of $59.44 per share. Total worth of this trade was $981,975. Total number of shares owned as of Dec 30 were 1,778,180
- SEC Form 4 filing: Nov 17: Sold 16,680 shares at the rate of $46.12 per share. Total worth of this trade was $769,343. Total number of shares owned as of Nov 17 were 1,778,180
Posted by
George Daniels
on Wednesday December 30 2020, 10:27 PM EDT.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
